Pancreatic Cysts

Immunovia completes development of blood test for pancreatic cancer

By Liz Carey

What's next for company after moving testing laboratory to North Carolina.

August 5, 2024

Growing AI healthcare market boasts variety of deployments

By Bruce Carlson

Population health, workflow improvements, diagnostics, and risk assessment are among the areas where artificial intelligence is already being deployed.

October 13, 2019

Second guessing thyroid cancer test | Artificial intelligence on show | Companies gear up for AACC

By Emily Hayes

Dear LabPulse Member,

July 22, 2019

AI-driven test helps make the call on pancreatic cysts

By Emily Hayes

The test -- dubbed comprehensive cyst, or CompCyst -- incorporates mutation status, loss of heterozygosity, aneuploidy, protein markers, and clinical data. An artificial intelligence algorithm is used to help identify which patients should have surgery and which ones can be followed safely.

July 21, 2019

Simple test of cystic fluid may help spare pancreatic surgeries

By Emily Hayes

In the blinded, retrospective analysis of 169 surgical samples from a range of tertiary referral centers, an enzyme-linked immunosorbent assay (ELISA) for the antibody Das-1 had an accuracy of 95% for identifying high-risk lesions and, therefore, which patients were most appropriate for surgery, reported a team led by Dr. Koushik Das, a Washington University gastroenterologist.

June 6, 2019